Artificial Intelligence and Machine Learning/Translation in Pharma Language Translation

MARK WADE | November 11, 2019

article image
AI, in practice, has a lot of potential and also a lot of limitations. AI is being used to model, extrapolate, and automate tasks throughout the lifecycle of a drug (as it should be). The potential benefits are substantial, both in terms of clinical efficacy and financial savings. The low-hanging fruit was big data analysis for drug interactions, as the data is easily consumable and analyzed by today’s AI. Amassed medical data on drugs can be easily compared against patient medications to alert study teams to potential risks. Patient recruitment, monitoring, and retention by way of analyzing large EMR data sets, both structured and unstructured, is a point of focus and is a similarly accessible and important use case for AI. Pinpointing patient heterogeneity, securing patients who are more likely to match the ever-increasing inclusion/exclusion criteria and also have the capacity to respond to certain treatments.

Spotlight

Compass Health Analytics, Inc.

Compass Health Analytics delivers thorough and accurate analysis of health care costs and financial risk, regulatory issues, and key strategic decisions. Our services actuarial and economic analysis, strategic financial planning, data management and warehousing, all delivered with our experience and insight help our health care clients improve efficiency and access in the populations they serve.

OTHER ARTICLES

Enabling Active Pharma Ingredients for Batch Balancing and Integration to SAP EWM

Article | April 6, 2020

Batch and its Classification system are two most potent weapons used in Chemical, Pharma or Medical life science industry to record the potency of a batch or technically called as Active Pharma Ingredients(API). These material consist of one or more active ingredients, concentrates, carrier materials, or impurities, and so on. The potency of the active ingredients varies from batch to batch. The active ingredient is the substance of greatest interest in the bill of materials, the proportion of which may vary from batch to batch. Therefore, during creation of a process order, the system must be able to select and adjust the batches needed to obtain the required amount of active ingredient. Take an example of a drug hydroxychloroquine which is used as potent weapon to fight COVID-19. This drug is manufactured by using API, however, the Potency of this API material vary from batch to batch. To map this kind of requirement in SAP ERP, SAP calls it as Material Quantity Calculation.

Read More

Roche Prepares to Launch COVID-19 Antibody Test System

Article | April 6, 2020

Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2, the virus that causes COVID-19. Roche is eying May for the launch of the test in Europe and is in talks with the U.S Food and Drug Administration for emergency approval of the system. Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms, the company said. Roche noted that as more information becomes available about immunity levels to COVID-19, society can return to a sense of normal much more quickly. Roche’s test will join a number of other antibody tests that have recently come on the market. Earlier this month the U.S. Food and Drug Administration approved the first blood test for COVID-19 antibodies.

Read More

How AI and Big Data Will Disrupt Pharma’s Regulatory Compliance Standards

Article | April 6, 2020

The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive. With more real-time automation and the steady increase in AI and Big Data sweeping the landscape, what used to be a slow-to-change and risk-averse industry is now expected to see a significant shift towards newer technology that focus on heightened regulatory standards. Here’s how your company can get ahead of what industry experts are calling, Pharma

Read More

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | April 6, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

Spotlight

Compass Health Analytics, Inc.

Compass Health Analytics delivers thorough and accurate analysis of health care costs and financial risk, regulatory issues, and key strategic decisions. Our services actuarial and economic analysis, strategic financial planning, data management and warehousing, all delivered with our experience and insight help our health care clients improve efficiency and access in the populations they serve.

Events